Sustainability And The Effective Role It Plays In Pharma

The pharma sector happens to be one of the most resource intensive verticals. The processes when it comes to manufacturing, packaging, as well as distributing the meds consume a massive amount of water, energy, as well as raw materials. As a matter of fact, a study in 2019 went on to find out that the […]

Smart Packaging – Making Way For A Surge In Drugs Demand

The pharma sector happens to be standing at a very significant crossroads that is driven by rapid advancement when it comes to automation technology. Such kinds of developments are indeed elevating the drug manufacturing processes as well as revolutionizing packaging along with the delivery of pharma products. As per one of the reports published by […]

A $400 Bn Pharmaceutical Packaging Market Is Up For Grabs

Advancements when it comes to manufacturing, demand in terms of sustainability, as well as an ongoing surge in terms of worldwide healthcare requirements, are in a way collectively pushing the pharmaceutical packaging market towards an unprecedented growth level. As per a recently published report that happens to predict the market performance over the next 10 […]

Moderna Receives EC Approval for RSV Vaccine mRESVIA

Moderna, Inc announced that the EC has granted marketing authorization for mRESVIA® (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. The marketing authorization follows the Positive Opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for […]

VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon Biosciences

VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION Biosciences LLC […]

ST Pharm and Quantoom Partner to Enhance RNA Manufacturing Flexibility

ST Pharm and Quantoom Biosciences have announced an extended collaboration to advance the development and manufacturing of RNA-based vaccines and therapeutics. This partnership integrates the complementary strengths of both companies to enhance the global supply of critical RNA manufacturing technologies. A key component of the collaboration is the initial supply agreement for ST Pharm’s proprietary […]

Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program

Bridge Biotherapeutics, a clinical-stage biotech company, announced that it has entered into a joint research agreement with HitGen Inc., a Chinese drug discovery platform company. This collaboration builds on successful initial hit finding and identification work from HitGen’s DNA-encoded library (DEL), aiming to further develop the novel hits as promising drug candidates for cancer. Bridge […]

FedEx Releases New Digital Visibility Products

FedEx customers now have access to new digital visibility products that enhance the shipper and recipient experience by connecting digital solutions with critical data. These new paid solutions help meet the growing market demand for advanced data analytics and will equip businesses with near real-time insights and predictive analytics to help improve the post-purchase experience […]

Novartis and Versant Ventures Launch Borealis Biosciences with $150M Investment

Novartis and Versant Ventures have launched Borealis Biosciences with a substantial $150 million Series A funding. The new biotech firm aims to develop next-generation xRNA-based medicines targeting kidney diseases. This venture marks a significant milestone in renal medicine and showcases an innovative deal structure in the pharmaceutical industry. Novartis, a global pharmaceutical giant, and Versant […]

New Endometrial Cancer Therapy Phase-II Trial Shows Promise

The most recent trial of a new antibody drug that goes on to deliver potent chemotherapy that too directly to the cancer cells for patients with advanced or recurrent endometrial cancer has gone a notch up to be studied a bit more in the phase III trial. The results of the phase II study that’s […]